GMDA NASDAQ
Gamida Cell Ltd.
1W: +111.0%
1M: +116.6%
3M: -91.2%
1Y: -98.0%
3Y: -99.5%
5Y: -99.5%
$0.03
Last traded 2025-06-17 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
#867
of 1064
Biotechnology
Technical Signal Map
3 Bullish
2 Neutral
8 Bearish
GMDA
—
Gamida Cell Ltd.
N/A
0
SLGL
$240M
Sol-Gel Technologies Ltd.
BULLISH
+66
DRTSW
$1.6B
Alpha Tau Medical Ltd.
BULLISH
+65
DRTS
$1.3B
Alpha Tau Medical Ltd
BULLISH
+40
CBI.TA
$40M
Clal Biotechnology Industries Ltd.
NEUTRAL
0
MDWD
$170M
MediWound Ltd.
LEAN BEAR
-10
PYPD
$100M
PolyPid Ltd.
LEAN BEAR
-27
ENTX
$140M
Entera Bio Ltd.
BEARISH
-50
BBIXF
$50M
Bonus Biogroup Ltd.
BEARISH
-52
BONS.TA
$210M
Bonus BioGroup Ltd.
BEARISH
-56
MTLF.TA
$80M
Matricelf Ltd.
BEARISH
-75
CGEN
$690M
Compugen Ltd.
BEARISH
-84
BLRX
$30M
BioLineRx Ltd.
BEARISH
-91
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| GMDA Gamida Cell Ltd. | — | -0.1 | 129.6 | -75.7 | 2241.1 | — | 2 | N/A | -98.0 |
| SLGL Sol-Gel Technologies Ltd. | $240M | -12.8 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | BULLISH | 144.1 |
| DRTSW Alpha Tau Medical Ltd. | $1.6B | -14.2 | -141.7 | -17.1 | — | — | 3 | BULLISH | 1253.3 |
| DRTS Alpha Tau Medical Ltd | $1.3B | -14.2 | -141.7 | -17.1 | — | — | 3 | BULLISH | 238.0 |
| CBI.TA Clal Biotechnology Industries Ltd. | $40M | -4.2 | -65.7 | -8.5 | -461.2 | — | 4 | NEUTRAL | -23.4 |
| MDWD MediWound Ltd. | $170M | -8.4 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | LEAN BEAR | -22.7 |
| PYPD PolyPid Ltd. | $100M | -3.5 | -1913.8 | 231.6 | — | — | 3 | LEAN BEAR | 54.0 |
| ENTX Entera Bio Ltd. | $140M | -8.2 | -138.9 | 314.4 | — | -100.0 | 1 | BEARISH | 54.6 |
| BBIXF Bonus Biogroup Ltd. | $50M | -17.8 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | -42.9 |
| BONS.TA Bonus BioGroup Ltd. | $210M | -17.8 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | -32.1 |
| MTLF.TA Matricelf Ltd. | $80M | -1.4 | -420.5 | -595.3 | — | — | 3 | BEARISH | 11.5 |
| CGEN Compugen Ltd. | $690M | 6.2 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | BEARISH | 44.4 |
| BLRX BioLineRx Ltd. | $30M | -1.4 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -38.8 |
| GMDA Gamida Cell Ltd. | — | -0.1 | 129.6 | -75.7 | 2241.1 | — | 2 | N/A | -98.0 |
| SLGL Sol-Gel Technologies Ltd. | $240M | -12.8 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | BULLISH | 144.1 |
| DRTSW Alpha Tau Medical Ltd. | $1.6B | -14.2 | -141.7 | -17.1 | — | — | 3 | BULLISH | 1253.3 |
| DRTS Alpha Tau Medical Ltd | $1.3B | -14.2 | -141.7 | -17.1 | — | — | 3 | BULLISH | 238.0 |
| CBI.TA Clal Biotechnology Industries Ltd. | $40M | -4.2 | -65.7 | -8.5 | -461.2 | — | 4 | NEUTRAL | -23.4 |
| MDWD MediWound Ltd. | $170M | -8.4 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | LEAN BEAR | -22.7 |
| PYPD PolyPid Ltd. | $100M | -3.5 | -1913.8 | 231.6 | — | — | 3 | LEAN BEAR | 54.0 |
| ENTX Entera Bio Ltd. | $140M | -8.2 | -138.9 | 314.4 | — | -100.0 | 1 | BEARISH | 54.6 |
| BBIXF Bonus Biogroup Ltd. | $50M | -17.8 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | -42.9 |
| BONS.TA Bonus BioGroup Ltd. | $210M | -17.8 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | -32.1 |
| MTLF.TA Matricelf Ltd. | $80M | -1.4 | -420.5 | -595.3 | — | — | 3 | BEARISH | 11.5 |
| CGEN Compugen Ltd. | $690M | 6.2 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | BEARISH | 44.4 |
| BLRX BioLineRx Ltd. | $30M | -1.4 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -38.8 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
GMDA vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
P/E Ratio
ROE
Piotroski F